Wednesday, September 12, 2018
A recent development shows that the immune response to cancer can be further enhanced using cytokines, small proteins that act as chemical messengers transporting information between different types of immune cells. A clinical trial led by Marc Ernstoff, MD, the Katherine Anne Gioia Chair of Medicine at Roswell Park Comprehensive Cancer Center, found that a drug complex containing one of these cytokines, interleukin-15 (IL-15), is both safe and well tolerated in patients with advanced solid tumors. The findings have been published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).
Thursday, September 06, 2018